The Unknown Risks of Senolytics

Peptides like FOXO4-DRI & PNC-27 show promise for reducing senescent cells & preventing cancer. But are we experimenting too soon?

FOXO4-DRI may be a powerful senolytic, yet human data is lacking. Senescent cells play key signaling roles, so wiping them out completely might backfire—especially for younger users. The challenge? Finding the right dose, frequency & age to start.

With new senolytic products emerging, is it time to experiment or wait for more research?

Learn more about Peptides & Other Biohacking Protocols on episode 196 of the Mind Body Peak Performance Podcast

• For the full episode: https://youtu.be/A56xR6onhtQ
• Show notes: https://mindbodypeak.com/196

🎤 Get weekly insider secrets from world-class experts:
/ @mindbodypeakperformance

🔔 Subscribe for more free "biohacking" Human Performance tips, product reviews, and the latest info:
/ @outliyr

🚀 Tools, products, & services I recommend:
https://outliyr.com/shop

🔥 Join my VIP club - It's a weekly newsletter sharing Human Performance tips, biohacking news, freebies, and more!
https://outliyr.com/vip

🔗 Links

• Music by Luke Hall: soundcloud.com/c_luke_hall

🙏 Support the show

• Subscribe: https://mindbodypeak.com/subscribe
• Leave an Apple Podcast review: https://mindbodypeak.com/rate-podcast

Do you have questions, thoughts or feedback? Let me know in the comments below and one of us will get back to you!

Disclaimers:
Nothing posted on this channel is medical advice or a substitute for advice from your physician or healthcare provider. Always contact your healthcare professional with any questions about a medical condition or your personal health. Additionally, some of the links provided above are affiliate links. They don't cost you anything, but I make a tiny commission from the sale. Honesty is key on my channel, and thank you for your support! You may read the full disclaimer here: https://outliyr.com/disclaimers